TY - JOUR A1 - v. Frankenberg, Jenny A1 - Seidl, Rainer Ottis A1 - Schultheiss, Corinna A1 - Frank, Ulrike A1 - Fuß, Sophia A1 - Stefke, Michaela A1 - Honekamp, Andrea A1 - Winkler, Silke A1 - Jäckel, Annemarie A1 - Schindler, Wencke A1 - Wenglarczyk, Anke A1 - Weise, Stefanie A1 - Heide, Judith A1 - Stadie, Nicole A1 - Schröder, Astrid A1 - Baer-Henney, Dinah A1 - van de Vijver, Ruben A1 - Sauerland, Uli A1 - Yatsushiro, Kazuko A1 - Schöppe, Doreen A1 - Blatter, Kristine A1 - Faust, Verena A1 - Jäger, Dana A1 - Artelt, Cordula A1 - Schneider, Wolfgang A1 - Stanat, Petra A1 - Bruchmüller, Wiebke A1 - Sjöström, Saana A1 - Schütz, Susann A1 - Swietza, Romy A1 - Zielina, Marie A1 - Freymann, Marie A1 - Hausmann, Nadin A1 - Köntopp, Isabelle A1 - Liebig, Johanna A1 - Schnell, Annemarie A1 - Wegener, Viktoria A1 - Heinemann, Steffi A1 - Haensel, Diana A1 - Mürbe, Dirk A1 - Pomnitz, Patricia A1 - Siegmüller, Julia ED - Heide, Judith ED - Fritzsche, Tom ED - Meyer, Corinna B. ED - Ott, Susan T1 - Spektrum Patholinguistik = Schwerpunktthema: Schluck für Schluck: Dysphagietherapie bei Kindern und Erwachsenen T1 - Spektrum Patholinguistik = Key issue: Sip by sip: Dysphagia therapy in children and adults N2 - Das Herbsttreffen Patholinguistik wird seit 2007 jährlich vom Verband für Patholinguistik e.V. (vpl) durchgeführt. Die Jubiläumsveranstaltung am 19.11.2011 in Potsdam war nicht nur die 5. Auflage der Veranstaltung, sondern auch ein Fest zum 10jährigen Bestehen des Verbandes. Das Thema lautete "Schluck für Schluck: Dysphagietherapie bei Kindern und Erwachsenen". Im vorliegenden Tagungsband finden sich die Artikel der Hauptvorträge sowie die Abstracts der Posterpräsentationen. N2 - The 'Herbsttreffen Patholinguistik' is an annual conference organized by the Association for Patholinguistics (Verband für Patholinguistik e.V./vpl) since 2007. The anniversary event on November 19th, 2011 in Potsdam marked both the 5th edition of this conference series and the 10th birthday of the vpl. The main topic of the meeting was "Sip by sip: Dysphagia therapy in children and adults". These proceedings contain the papers from the invited talks and the abstracts of the poster presentations. T3 - Spektrum Patholinguistik - 5 KW - Patholinguistik KW - Sprachtherapie KW - Dysphagie KW - Schluckstörung KW - Schlucktherapie KW - patholinguistics KW - speech/language therapy KW - dysphagia KW - swallowing disorders KW - dysphagia therapy Y1 - 2012 U6 - http://nbn-resolving.de/urn/resolver.pl?urn:nbn:de:kobv:517-opus-59877 SN - 978-3-86956-199-8 SN - 1866-9433 SN - 1869-3822 IS - 5 PB - Universitätsverlag Potsdam CY - Potsdam ER - TY - JOUR A1 - Döge, Nadine A1 - Hönzke, Stefan A1 - Schumacher, Fabian A1 - Balzus, Benjamin A1 - Colombo, Miriam A1 - Hadam, Sabrina A1 - Rancan, Fiorenza A1 - Blume-Peytavi, Ulrike A1 - Schäfer-Korting, Monika A1 - Schindler, Anke A1 - Rühl, Eckart A1 - Skov, Per Stahl A1 - Church, Martin K. A1 - Hedtrich, Sarah A1 - Kleuser, Burkhard A1 - Bodmeier, Roland A1 - Vogt, Annika T1 - Ethyl cellulose nanocarriers and nanocrystals differentially deliver dexamethasone into intact, tape-stripped or sodium lauryl sulfate-exposed ex vivo human skin - assessment by intradermal microdialysis and extraction from the different skin layers JF - Journal of controlled release N2 - Understanding penetration not only in intact, but also in lesional skin with impaired skin barrier function is important, in order to explore the surplus value of nanoparticle-based drug delivery for anti-inflammatory dermatotherapy. Herein, short-termex vivo cultures of (i) intact human skin, (ii) skin pretreated with tape-strippings and (iii) skin pre-exposed to sodium lauryl sulfate (SLS) were used to assess the penetration of dexamethasone (Dex). Intradermal microdialysis was utilized for up to 24 h after drug application as commercial cream, nanocrystals or ethyl cellulose nanocarriers applied at the therapeutic concentration of 0.05%, respectively. In addition, Dex was assessed in culture media and extracts from stratum corneum, epidermis and dermis after 24 h, and the results were compared to those in heat-separated split skin from studies in Franz diffusion cells. Providing fast drug release, nanocrystals significantly accelerated the penetration of Dex. In contrast to the application of cream and ethyl cellulose nanocarriers, Dex was already detectable in eluates after 6 h when applying nanocrystals on intact skin. Disruption of the skin barrier further accelerated and enhanced the penetration. Encapsulation in ethyl cellulose nanocarriers delayed Dex penetration. Interestingly, for all formulations highly increased concentrations in the dialysate were observed in tape-stripped skin, whereas the extent of enhancement was less in SLS-exposed skin. The results were confirmed in tissue extracts and were in line with the predictions made by in vitro release studies and ex vivo Franz diffusion cell experiments. The use of 45 kDa probes further enabled the collection of inflammatory cytokines. However, the estimation of glucocorticoid efficacy by Interleukin (IL)-6 and IL-8 analysis was limited due to the trauma induced by the probe insertion. Ex vivo intradermal microdialysis combined with culture media analysis provides an effective, skin-sparing method for preclinical assessment of novel drug delivery systems at therapeutic doses in models of diseased skin. (C) 2016 Elsevier B.V. All rights reserved. KW - Drug delivery systems KW - Polymeric nanoparticles KW - Dexamethasone KW - Microdialysis KW - Skin penetration KW - Skin barrier disruption Y1 - 2016 U6 - https://doi.org/10.1016/j.jconrel.2016.07.009 SN - 0168-3659 SN - 1873-4995 VL - 242 SP - 25 EP - 34 PB - Elsevier CY - Amsterdam ER -